This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)
C3_SECONDARY_NAS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
9433 |
4. Check minimum number of eventsNone |
9433 |
5. Include endpointsNone |
9433 |
6. Filter based on genotype QC (FinnGen only) |
9433 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 9433 | 4278 | 5155 |
| Unadjusted period prevalence (%) | 1.90 | 1.46 | 2.27 |
| Median age at first event (years) | 69.68 | 67.39 | 71.58 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 324
- Matched controls
- 3238
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
444.7
239.4
214
14
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
208.6
177
*
130
Kela drug reimbursment
Malignant tumour
+∞
203.2
173
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
165.1
144
*
A03FA01
ATC
metoclopramide; systemic, rectal
35.2
156.5
228
204
JN4BD
NOMESCO Finland
Extensive body CT
56.9
152.8
182
71
Z51.5
ICD-10 Finland
Palliative care
98.5
151.3
161
32
N02AA05
ATC
oxycodone; systemic
31.9
146.6
217
193
A04AA02
ATC
granisetron; systemic, transdermal
1889.9
133.0
120
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
130.2
116
*
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
105.0
95
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
103.9
94
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
96.8
88
*
XX3DW
NOMESCO Finland
Time consuming IT work
31.2
91.0
124
63
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
86.4
79
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
11.2
84.3
215
483
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
72.7
67
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
65.9
61
*
M05BX04
ATC
denosumab; parenteral
27.2
64.3
90
45
C61
ICD-10 Finland
Malignant neoplasm of prostate
744.5
64.1
61
*
116
Kela drug reimbursment
Prostate cancer
+∞
61.4
57
*
JN4CD
NOMESCO Finland
Very extensive body CT
56.4
60.7
71
16
L01BC06
ATC
capecitabine; oral
+∞
59.2
55
*
115
Kela drug reimbursment
Breast cancer
+∞
57.0
53
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
26.9
55.1
77
37
A04AA01
ATC
ondansetron; systemic, rectal
32.7
54.6
72
28
NK6AN
NOMESCO Finland
Total body bone isotope imaging
191.5
48.3
49
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
48.1
45
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
73.5
44.6
50
8
L03AA13
ATC
pegfilgrastim; parenteral
+∞
43.7
41
*
L02BG04
ATC
letrozole; oral
476.7
43.2
42
*
L02AE02
ATC
leuprorelin; implant, parenteral
123.4
40.8
43
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
155.8
39.7
41
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
38.3
36
*
A04AD12
ATC
aprepitant; systemic
+∞
37.2
35
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.7
37.0
222
1029
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
36.1
34
*
WW500
NOMESCO Finland
Blood transfusion
27.2
35.7
49
21
WZC30
NOMESCO Finland
Teaching
7.3
35.2
93
168
L02BB03
ATC
bicalutamide; oral
+∞
35.0
33
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
35.0
33
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
33.9
32
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
369.9
33.5
33
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
32.9
31
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
31.8
30
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
31.8
30
*
PJA12
NOMESCO Finland
Sentinel node biopsy
344.2
31.4
31
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
344.2
31.4
31
*
JN4AD
NOMESCO Finland
Body CT examination
14.9
31.2
53
42
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
30.7
29
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
30.7
29
*
L02BA01
ATC
tamoxifen; oral
331.5
30.3
30
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
29.6
28
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
29.6
28
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
318.9
29.3
29
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.5
29.1
83
163
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
28.6
27
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
306.4
28.2
28
*
Y77
ICPC
Malignant neoplasm prostate
306.4
28.2
28
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
27.5
26
*
L02BB04
ATC
enzalutamide; oral
+∞
27.5
26
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
19.4
27.0
41
24
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
26.4
25
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
26.4
25
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
26.4
25
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
24.3
23
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.8
23.5
72
152
WX302
NOMESCO Finland
Thoracal epidural anesthesy
19.4
23.2
35
20
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
23.2
22
*
L02BA03
ATC
fulvestrant; parenteral
+∞
23.2
22
*
L01CA04
ATC
vinorelbine; systemic
+∞
23.2
22
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
23.2
22
*
A02BC02
ATC
pantoprazole; systemic
3.6
23.1
252
1595
X76
ICPC
Malignant neoplasm breast female
+∞
22.1
21
*
192
Kela drug reimbursment
Fulvestrant
+∞
22.1
21
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
22.1
21
*
B01AB10
ATC
tinzaparin; parenteral
8.4
22.0
50
69
ZX120
NOMESCO Finland
Intravenous
6.9
21.8
57
97
HA1AA
NOMESCO Finland
X-ray mammography
14.2
21.8
37
29
A06AH03
ATC
naloxegol; oral
46.9
21.7
26
6
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.3
21.4
147
649
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
6.0
21.2
62
123
L03AA02
ATC
filgrastim; parenteral
+∞
21.1
20
*
A79
ICPC
Malignancy NOS
117.6
20.8
22
*
L02AE03
ATC
goserelin; implant
223.7
20.8
21
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
21.9
20.8
30
15
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
22.6
20.3
29
14
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
20.0
19
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
20.0
19
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
15.3
19.5
32
23
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.6
19.5
47
71
B01AB05
ATC
enoxaparin; parenteral
3.3
19.4
130
553
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
18.9
18
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
17.9
17
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
17.9
17
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
17.9
17
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
39.1
17.8
22
6
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
67.0
16.9
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
16.9
109
445
A04AA55
ATC
palonosetron, combinations; systemic
+∞
16.8
16
*
L02BX03
ATC
abiraterone; oral
+∞
16.8
16
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
16.5
16.5
26
17
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
50.2
16.2
19
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
15.7
15
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
15.7
15
*
L02BX02
ATC
degarelix; parenteral
+∞
15.7
15
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
15.4
66
194
J01MA12
ATC
levofloxacin; systemic
3.2
15.2
96
381
HAB40
NOMESCO Finland
Wedge excision of mammary gland
33.5
15.0
19
6
R50.9
ICD-10 Finland
Fever, unspecified
3.9
14.9
67
205
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
14.7
14
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.5
14.6
55
142
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
13.8
83
317
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.9
13.7
46
106
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
13.6
13
*
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
+∞
13.6
13
*
L02BG06
ATC
exemestane; oral
+∞
13.6
13
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
13.6
13
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
13.6
13
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
13.6
13
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
13.6
13
*
N02BE01
ATC
paracetamol; systemic, rectal
3.4
13.3
290
2315
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.6
13.3
48
119
ZX112
NOMESCO Finland
Subcutaneous
21.1
12.6
18
9
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
12.6
12
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.6
12
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
12.6
12
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
12.6
12
*
R83
ICPC
Respiratory infection other
0.0
12.5
*
297
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.7
12.5
43
101
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
134.9
12.5
13
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
134.9
12.5
13
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.1
12.2
74
280
SPAT1254
SPAT
Administration of medicine
3.2
11.9
70
260
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
17.2
11.8
18
11
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.7
11.7
54
167
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
11.5
11
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
11.5
11
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
11.5
11
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
11.5
11
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
+∞
11.5
11
*
L01CB01
ATC
etoposide; systemic
+∞
11.5
11
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
11.5
11
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
11.5
11
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
11.5
11
*
1501
Kela drug reimbursment
Palbociclib
+∞
11.5
11
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
124.2
11.5
12
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.9
11.4
80
331
N02AX02
ATC
tramadol; systemic, rectal
2.3
11.2
158
956
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.0
11.1
45
125
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
44.9
11.0
13
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
62.1
10.7
12
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
10.5
10
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
10.5
10
*
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
+∞
10.5
10
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
10.5
10
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
10.5
10
*
L01XE33
ATC
[U] palbociclib; oral
+∞
10.5
10
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
10.5
10
*
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
+∞
10.5
10
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
10.5
10.2
19
19
J94.8
ICD-10 Finland
Other specified pleural conditions
15.2
10.1
16
11
NF3AA
NOMESCO Finland
Femur X-ray examination
8.8
9.7
20
24
TGD00
NOMESCO Finland
Needle biopsy of lung
56.7
9.7
11
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
18.2
9.5
14
8
WF099
NOMESCO Finland
Other radiotherapy
102.9
9.5
10
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
9.4
9
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
9.4
9
*
L01AX03
ATC
temozolomide; systemic
+∞
9.4
9
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
9.4
9
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
+∞
9.4
9
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
9.4
9
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
9.4
9
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
9.4
9
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
37.8
9.1
11
*
A06AD11
ATC
lactulose; oral
2.6
9.0
71
315
N03AX14
ATC
levetiracetam; systemic
8.3
9.0
19
24
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
8.8
104
565
N03AX16
ATC
pregabalin; oral
2.3
8.7
92
474
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
8.5
81
393
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.0
8.4
*
204
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
8.4
8
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
8.4
8
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
8.4
8
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
+∞
8.4
8
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
8.4
8
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
8.4
8
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
8.4
8
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
8.4
8
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
8.4
8
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
8.4
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
8.4
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.4
8
*
394
Kela drug reimbursment
Palbociclib
+∞
8.4
8
*
180
Kela drug reimbursment
Interferon alfa
+∞
8.4
8
*
L17
ICPC
Foot/toe symptom/complaint
0.3
8.2
17
529
SPAT1109
SPAT
Analgesia with portable analgesic pump
34.3
8.1
10
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
10.4
8.1
15
15
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.2
8.1
30
77
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
22.7
8.1
11
5
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.0
8.1
149
970
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.9
8.0
25
54
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.1
8.0
*
252
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.7
8.0
22
41
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
25.7
7.6
10
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.3
7.5
38
127
N02AA01
ATC
morphine; systemic, rectal
13.8
7.4
12
9
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
6.0
7.3
19
33
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
7.3
7
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
7.3
7
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
7.3
7
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
7.3
7
*
GDC00
NOMESCO Finland
Lobectomy of lung
+∞
7.3
7
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
7.3
7
*
1CD02
NOMESCO Finland
NA
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
7.3
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
7.3
7
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
L01XE23
ATC
[U] dabrafenib; oral
+∞
7.3
7
*
R84
ICPC
Malignant neoplasm bronchus/lung
+∞
7.3
7
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
+∞
7.3
7
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
7.3
7
*
GA5AA
NOMESCO Finland
Rib X-ray examination
+∞
7.3
7
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
7.3
7
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
+∞
7.3
7
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
7.3
7
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
+∞
7.3
7
*
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
7.3
7
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
7.3
7
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
20.6
7.2
10
5
TKE00
NOMESCO Finland
Needle biopsy of prostate
4.9
7.2
22
47
H02AB06
ATC
prednisolone; systemic
1.9
7.0
160
1105
WW200
SPAT
NA
0.0
6.9
*
169
SPAT1111
SPAT
Planning of analgesia
12.6
6.6
11
9
A41.9
ICD-10 Finland
Sepsis, unspecified
4.7
6.6
21
47
C03CA01
ATC
furosemide; systemic
1.9
6.6
125
805
JFF23
NOMESCO Finland
Transversostomy
71.2
6.4
7
*
L02BG03
ATC
anastrozole; oral
71.2
6.4
7
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
9.5
6.3
12
13
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
6.3
6
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
6.3
6
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
6.3
6
*
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
+∞
6.3
6
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
6.3
6
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
6.3
6
*
197
Kela drug reimbursment
Sunitinib
+∞
6.3
6
*
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
+∞
6.3
6
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
6.3
6
*
L01XE25
ATC
[U] trametinib; oral
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
D75
ICPC
Malignant neoplasm colon/rectum
+∞
6.3
6
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
+∞
6.3
6
*
159
Kela drug reimbursment
Pazopanib
+∞
6.3
6
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
6.3
6
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
6.3
6
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
6.3
6
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
6.3
6
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
6.3
6
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
6.3
6
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
6.3
6
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
6.3
6
*
L01BC53
ATC
tegafur, combinations; systemic
+∞
6.3
6
*
A98
ICPC
Health maint/preventive medicine
0.5
6.2
229
2674
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
12.8
6.1
10
8
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
12.8
6.1
10
8
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
12.8
6.1
10
8
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
6.1
70
371
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
6199
77472
0.42
323.01
3.6
4.8
mmol/l
1.4
1.4
8.82
5339
70764
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2608
12349
2.54
321.19
2.3
1.9
s
29.6
30.0
2.65
2547
11953
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
506
771
6.88
317.54
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
6303
78122
0.42
316.11
3.6
4.9
mmol/l
4.6
4.5
6.70
5417
71865
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
686
1419
5.13
312.73
1.4
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1459
5168
3.16
312.00
1.6
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
3807
21577
2.28
309.45
3.6
3.0
e6/l
0.7
0.4
4.86
3135
16075
(3013650) Neutrophils [#/volume] in Blood by Automated count
7856
40839
6.52
307.65
28.7
6.3
e9/l
4.1
4.3
13.14
7400
34902
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1712
6246
3.13
307.65
7.9
3.1
mmol/l
1.2
1.2
1.59
1660
5262
(3015377) Calcium [Moles/volume] in Serum or Plasma
5888
24095
4.84
307.65
13.4
2.1
mmol/l
2.3
2.4
4.45
5616
20016
(3013115) Eosinophils [#/volume] in Blood
5881
38611
2.39
307.65
6.9
5.5
e9/l
0.2
0.2
61.79
5165
33460
(42870588) Differential panel, method unspecified - Blood
4610
25183
2.62
307.65
6.4
5.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1867
5784
3.78
307.65
2.4
2.0
g/l
0.2
0.2
9.44
1779
5242
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
3453
16783
2.67
307.65
3.2
2.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
4545
24265
2.68
307.65
4.5
2.3
u/l
54.7
60.0
6.63
4336
22160
(40768441) Liver Pathology biopsy report
373
313
12.37
307.65
1.1
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
8062
37469
8.92
307.65
23.6
3.8
umol/l
10.4
12.1
28.61
7965
35043
(3006504) Eosinophils/100 leukocytes in Blood
5623
34470
2.56
307.65
6.6
5.6
%
2.4
3.0
68.15
5393
31699
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
8412
58709
5.00
307.65
27.2
5.5
u/l
111.0
76.0
149.61
8283
54276
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
4890
27876
2.57
307.65
3.7
3.2
—
0.8
—
0
6
(3022096) Basophils/100 leukocytes in Blood
5502
33457
2.55
307.65
6.7
5.7
%
0.6
0.7
28.97
5280
30808
(4035726)
3332
2288
21.97
307.65
1.5
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
5606
20985
5.12
307.65
5.7
4.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
4326
4316
17.67
307.65
7.8
1.5
ug/l
79.3
9.9
8.48
3953
3263
(3018010) Neutrophils/100 leukocytes in Blood
5482
35046
2.35
307.65
6.6
5.6
%
61.6
57.8
77.53
5260
32340
(3019069) Monocytes/100 leukocytes in Blood
5686
34644
2.61
307.65
6.8
5.9
%
9.0
8.8
3.90
5461
32004
(3035637) Corticotropin [Mass/volume] in Plasma
539
634
8.96
307.65
1.7
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1656
6147
3.05
307.65
5.6
1.8
nmol/l
402.3
365.3
8.42
1603
5550
(40768793) Breast Pathology biopsy report
450
389
12.10
307.65
1.3
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
4631
21780
3.21
307.65
3.4
2.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
6796
35441
4.28
307.65
9.8
5.4
mmol/l
1.2
1.2
0.28
6596
31377
(3002030) Lymphocytes/100 leukocytes in Blood
5756
35391
2.61
307.65
6.8
5.7
%
22.1
27.2
186.80
5505
32485
(3013826) Glucose [Moles/volume] in Serum or Plasma
6982
46503
2.93
307.65
6.9
4.5
mmol/l
6.9
6.9
0.01
6797
43394
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
7369
39184
5.02
307.65
12.5
5.9
mmol/l
1.2
1.2
1.11
5999
32892
(3018418) pH of Serum or Plasma
5002
22736
3.55
307.65
7.9
3.4
ph
7.4
7.4
6.40
1416
3961
(3024561) Albumin [Mass/volume] in Serum or Plasma
6695
32434
4.67
307.65
9.9
3.9
g/l
32.1
35.5
307.65
6461
29630
(3006315) Basophils [#/volume] in Blood
5756
37388
2.38
307.65
6.7
5.4
e9/l
0.0
0.0
38.25
5017
31919
(3019198) Lymphocytes [#/volume] in Blood
5855
38133
2.41
307.65
6.8
5.4
e9/l
1.6
1.8
15.22
5163
33124
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1347
2128
7.22
307.65
6.0
1.5
u/ml
102.7
27.9
13.61
1325
2022
(3033658) Prothrombin time (PT) actual/Normal
3628
18212
2.61
307.65
6.2
3.6
%
88.7
86.2
8.14
3574
17736
(3002256) Pathology report gross observation
1744
6191
3.23
307.65
1.4
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
1301
3094
4.72
307.65
2.0
1.9
ug/l
3.1
1.8
0.63
1216
2696
(3026782) Osmolality of Urine
3076
14956
2.57
307.65
3.3
2.7
mosm/kgh2o
532.5
552.8
6.02
2790
12504
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
1239
945
14.94
307.65
5.4
1.9
u/ml
1232.1
1036.8
0.10
1154
853
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
710
375
20.39
307.65
5.3
1.7
nmol/l
14.6
4.7
4.09
705
360
(40768800) Prostate Pathology biopsy report
477
609
8.20
307.65
1.1
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
796
65
133.65
307.65
8.6
1.1
u/ml
112.4
20.2
15.13
789
60
(3012095) Magnesium [Moles/volume] in Serum or Plasma
4017
11476
5.35
307.65
5.7
2.5
mmol/l
0.8
0.8
42.27
3901
10491
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5741
33036
2.88
307.65
5.7
3.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
279
18
159.68
307.65
1.1
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
6465
79917
0.39
307.65
3.9
5.5
mmol/l
2.7
2.6
7.03
5500
73217
(3002582) Erythrocytes [#/volume] in Urine
4278
23430
2.51
307.65
3.7
3.1
e6/l
116.5
103.3
0.17
3564
17838
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
3703
13740
3.79
307.65
9.1
2.2
mmol/l
2.5
2.4
68.36
3520
11756
(40768804) Tissue Pathology biopsy report
4716
24661
2.82
307.65
2.6
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
6067
33192
3.32
307.65
7.8
10.4
inr
1.2
1.3
44.88
1896
9141
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
476
624
7.98
307.65
2.8
1.9
u/ml
650.4
454.8
0.16
465
607
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
851
1025
9.03
307.65
1.3
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
1533
1555
11.58
307.65
6.0
1.9
u/ml
2377.0
83.3
2.90
1379
1264
(3001604) Monocytes [#/volume] in Blood
5733
37143
2.39
307.65
6.7
5.4
e9/l
0.6
0.6
1.28
4990
31685
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2773
7860
4.58
307.65
6.0
2.7
u/l
284.3
241.0
16.40
2705
7290
(3031040) Bacteria [#/volume] in Urine by Automated count
7134
50584
2.68
307.65
5.3
4.4
e6/l
650.6
1559.7
1.45
129
765
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2968
12820
2.92
307.65
2.0
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
3793
17170
3.02
307.65
22.9
4.8
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
1088
446
27.44
307.65
2.5
1.3
ug/l
30.1
20.1
3.21
1071
431
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
1018
101
112.86
307.65
9.8
1.0
u/ml
103.0
23.4
10.41
1002
90
(3018095) Leukocytes [#/volume] in Urine
4471
27244
2.22
302.21
4.4
3.5
e6/l
124.9
111.9
0.40
3655
19248
(3004809) Band form neutrophils/100 leukocytes in Blood
534
929
6.03
293.82
2.1
2.9
%
2.0
1.2
4.56
418
704
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
921
2520
3.94
293.27
2.5
3.2
u/ml
0.4
0.3
0.41
548
1509
(3014576) Chloride [Moles/volume] in Serum or Plasma
2157
9718
2.58
291.40
7.4
6.7
mmol/l
103.7
104.3
7.37
2123
9485
(3042936) Bacteria identified in Isolate by Culture
2280
10559
2.53
290.56
1.9
2.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
3943
23178
2.20
287.70
3.5
3.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
3613
20643
2.22
281.61
3.5
3.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
3040
16300
2.28
275.73
2.9
2.5
e6/l
6.3
4.7
6.10
2759
14089
(3017446) Testosterone [Moles/volume] in Serum or Plasma
1318
4744
3.07
271.99
2.4
2.1
nmol/l
4.0
14.5
307.42
1087
4113
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1992
8899
2.57
271.90
1.9
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1986
8891
2.56
269.66
1.9
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
205
104
20.13
267.03
1.1
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1266
4521
3.08
264.49
1.7
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
344
420
8.46
261.81
1.2
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
414
639
6.73
256.16
1.4
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
6060
74924
0.47
252.28
5.6
6.5
mmol/mol
41.4
40.6
5.69
5345
68813
(3017181) Myelocytes/100 leukocytes in Blood
1508
6103
2.75
249.40
3.0
3.7
%
1.4
0.8
14.71
895
1306
(3003434) Protein [Mass/volume] in Pleural fluid
485
907
5.58
246.74
1.3
1.5
g/l
37.1
29.7
27.55
455
801
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1756
7788
2.54
240.58
4.2
2.2
umol/l
16.6
8.1
13.87
1578
6706
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
641
1565
4.32
237.14
1.4
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3790
23274
2.05
233.57
6.9
2.6
u/l
44.5
35.1
2.79
3666
21834
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
6115
74908
0.48
233.13
3.4
4.3
mmol/l
1.4
1.3
16.99
5246
67839
(3037121) Protein [Mass/volume] in Urine
847
2560
3.54
231.33
6.1
2.6
g/l
0.2
0.3
13.26
663
938
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2046
9907
2.36
229.98
4.9
5.6
mmol/l
1.0
1.0
2.02
1935
9114
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
520
1102
4.94
229.37
1.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
618
1507
4.32
228.86
1.4
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
862
22276
0.33
226.71
1.5
1.6
mmol/l
1.6
1.3
8.26
713
18351
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1158
4362
2.89
217.70
4.7
7.5
mmol/l
24.8
24.8
0.12
1147
4317
(3020779) Urea [Moles/volume] in Serum or Plasma
1585
7107
2.48
209.71
6.3
7.2
mmol/l
8.7
11.0
28.41
1509
6708
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1457
6380
2.52
202.31
3.6
2.2
u/l
42.5
46.1
0.18
1312
5380
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1675
7896
2.36
197.23
5.3
3.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
196
162
12.33
197.12
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
710
2136
3.51
194.43
1.6
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
1354
5865
2.53
191.70
3.1
3.7
%
0.2
0.1
6.45
797
1215
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
143
68
21.34
191.31
9.2
1.2
—
—
—
0
0
(4281824)
275
388
7.27
184.59
1.2
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
365
690
5.46
183.05
1.3
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
396
817
5.02
179.84
1.4
1.5
e6/l
2079.9
2476.1
0.34
297
597
(3012501) Base excess in Blood by calculation
606
1739
3.66
177.97
3.8
4.3
mmol/l
2.8
2.5
1.42
435
1165
(3013290) Carbon dioxide [Partial pressure] in Blood
606
1741
3.65
177.66
3.8
4.3
kpa
5.0
5.0
0.70
596
1697
(3003694) ABO and Rh group [Type] in Blood
2959
17954
1.94
177.41
1.5
1.3
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
607
1755
3.63
176.24
3.8
4.3
kpa
8.7
8.4
3.55
597
1710
(40760892) CBC W Ordered Manual Differential panel - Blood
2637
15433
1.98
175.38
5.2
4.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
203
210
9.86
175.33
2.2
3.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
4685
33105
1.82
172.09
20.8
8.7
e9/l
0.0
0.0
4.72
3893
27062
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
2208
12264
2.04
169.32
3.5
2.8
e6/l
2.6
2.3
0.80
1400
6651
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
499
1301
3.99
168.09
4.0
3.3
%
60.6
58.4
2.50
499
1301
(3002179) Metamyelocytes/100 leukocytes in Blood
1258
5600
2.44
166.43
3.0
3.5
%
1.0
0.6
6.63
594
984
(3028308) Erythrocytes [#/volume] in Pleural fluid
358
734
5.03
163.67
1.3
1.5
e6/l
33908.1
63109.9
1.37
229
430
(3010421) pH of Blood
642
2023
3.33
162.79
3.8
4.2
ph
7.4
7.4
0.95
597
1697
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
322
610
5.43
160.99
1.2
1.3
u/l
484.5
314.8
1.83
310
577
(3036782) Glucose [Moles/volume] in Pleural fluid
315
596
5.43
157.69
1.3
1.4
mmol/l
6.0
6.7
3.12
297
543
(3014111) Lactate [Moles/volume] in Serum or Plasma
1411
6752
2.28
157.58
5.2
6.9
mmol/l
1.5
1.4
1.17
1338
6509
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
741
2593
3.02
157.29
2.2
2.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
397
920
4.46
156.30
1.4
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1971
10780
2.05
156.13
2.1
2.7
%
21.0
22.6
4.22
1766
9009
(3042631) Mycobacterium sp identified in Specimen
419
1016
4.27
155.55
1.8
3.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
650
2143
3.18
152.79
1.2
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
1743
9204
2.10
151.34
5.6
7.2
mmol/l
1.4
1.3
0.59
1361
7155
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2051
11546
1.99
148.97
2.1
2.6
g/l
2.2
2.3
18.59
1940
10595
(40761536) Microorganisms panel - Urine sediment
1293
6099
2.30
148.84
4.8
4.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1735
9239
2.08
146.85
5.6
7.2
kpa
5.0
5.1
0.28
1650
8807
(3027801) Oxygen [Partial pressure] in Arterial blood
1734
9232
2.08
146.84
5.6
7.2
kpa
13.2
11.6
22.99
1645
8789
(3009214) Lutropin [Units/volume] in Serum or Plasma
452
1225
3.82
143.90
1.7
1.3
u/l
15.7
9.9
9.69
376
976
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
331
709
4.80
143.57
1.4
1.5
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
129
94
13.90
139.80
8.8
1.5
u/l
52.2
53.0
0.02
53
36
(3000991) Gas panel - Venous blood
1308
6399
2.21
137.10
6.4
8.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
1188
5593
2.29
136.66
3.2
3.8
%
0.1
0.2
0.68
664
1068
(3022948) Iron [Moles/volume] in Serum or Plasma
2138
12557
1.91
135.30
2.2
2.6
umol/l
11.1
12.9
22.31
2031
11517
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
254
460
5.65
133.27
1.4
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
6598
53632
1.77
132.32
5.4
4.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
543
1755
3.22
131.59
3.3
3.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
6790
77590
0.55
130.88
4.5
5.0
mmol/l
6.2
6.1
6.84
5949
70167
(3045788) Cell count panel - Pleural fluid
294
619
4.87
130.12
1.4
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
431
1226
3.64
127.68
1.4
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
792
3247
2.57
123.32
2.2
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
364
953
3.93
121.54
1.4
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
171
226
7.69
121.48
1.3
1.4
%
63.1
64.4
0.16
145
185
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
384
1071
3.69
117.04
1.4
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
4391
32713
1.64
115.51
4.2
3.9
ng/l
34.5
83.2
4.43
3735
23864
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
8551
76550
2.25
115.10
38.3
13.6
mg/l
35.9
24.2
157.69
8225
60228
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
381
1072
3.66
114.61
2.3
5.5
iu/ml
6661.5
942.1
0.47
37
158
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
351
937
3.85
113.98
1.4
1.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
354
951
3.83
113.92
1.5
1.4
pmol/l
267.0
75.7
4.09
346
924
(40767503) Oxygen content in Capillary blood by calculation
501
1683
3.09
113.49
2.4
2.5
%
15.1
16.5
7.53
221
905
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1393
7489
2.01
112.16
6.2
8.0
g/l
114.3
122.7
44.52
1346
7209
(3016502) Oxygen saturation in Arterial blood
1510
8352
1.96
112.04
6.0
7.5
%
95.5
95.2
0.76
1446
8035
(3014007) Fractional oxyhemoglobin in Arterial blood
1016
4874
2.22
110.41
7.0
9.2
%
94.2
93.5
3.00
1011
4858
(3002032) Base excess in Venous blood by calculation
1414
7708
1.98
109.21
3.6
3.8
mmol/l
2.1
1.9
1.03
1126
6296
(1617658) Protocol used for examination of sentinel lymph nodes
116
9
130.48
108.26
1.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
718
2990
2.52
107.77
2.0
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1411
7720
1.97
107.71
3.6
3.8
kpa
5.7
5.8
5.81
1365
7501
(3012544) pH of Venous blood
1447
8027
1.95
105.94
3.5
3.9
ph
7.4
7.4
—
6
37
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
230
477
4.92
103.58
1.2
1.3
u/l
11.1
11.9
0.51
217
433
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
247
544
4.64
103.45
1.5
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
277
677
4.18
101.53
2.3
3.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
398
1247
3.29
101.20
1.8
1.9
mmol/l
1.8
1.7
1.09
390
1223
(3001893) Eosinophils/100 leukocytes in Pleural fluid
144
193
7.56
101.06
1.3
1.4
%
3.2
2.3
0.54
125
163
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
986
4858
2.15
99.71
6.9
9.2
%
0.7
0.7
3.32
977
4826
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
192
356
5.48
98.17
1.5
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
191
353
5.50
98.00
1.5
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
248
574
4.41
97.59
1.4
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
248
574
4.41
97.59
1.4
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
248
574
4.41
97.59
1.4
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
197
377
5.32
97.28
1.2
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
970
4799
2.14
96.92
1.9
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
498
1822
2.83
96.55
1.8
2.4
g/l
3.9
3.6
2.72
484
1720
(3023183) Ammonium ion [Moles/volume] in Plasma
452
1572
2.97
96.14
2.0
2.6
umol/l
39.3
33.1
3.62
341
1341
(3020630) Protein [Mass/volume] in Serum or Plasma
1248
6822
1.96
94.62
3.9
1.6
g/l
64.5
66.8
18.57
1162
6110
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
205
421
4.95
93.39
1.4
1.3
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
974
4901
2.10
92.93
6.8
9.0
%
1.4
1.4
0.24
965
4868
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
236
547
4.40
92.69
1.7
1.3
u/l
32.6
32.6
0.01
227
396
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2094
13530
1.70
91.08
3.2
2.6
e6/l
2.7
1.1
0.69
1281
7851
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
148
236
6.35
88.45
8.8
1.2
u/ml
148.2
197.3
0.23
53
57
(3030981) Hyaline casts [#/volume] in Urine by Automated count
867
4253
2.14
88.20
3.4
2.6
e6/l
0.4
0.3
1.16
855
4157
(3017354) Segmented neutrophils/100 leukocytes in Blood
247
646
3.90
82.49
2.0
2.8
%
61.9
61.0
0.22
144
427
(3019225) pH of Specimen
1386
8187
1.81
81.63
9.2
3.6
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
78
0
+∞
81.35
1.1
0.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
2909
20894
1.57
80.76
4.8
4.1
estimate
0.0
0.0
0.10
1181
6342
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
430
1600
2.77
80.58
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
430
1600
2.77
80.58
1.3
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
1520
9272
1.76
80.12
2.5
2.1
%
2.0
1.8
8.72
1385
8081
(3033799) Differential panel - Peritoneal fluid
124
183
6.85
79.81
1.3
2.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
250
677
3.77
79.44
1.4
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2808
20105
1.56
78.59
1.9
2.3
mg/l
3.6
2.9
25.45
2458
17060
(3000919) Neutrophils/100 leukocytes in Pleural fluid
122
180
6.85
78.54
1.3
1.4
%
17.6
22.3
1.02
112
160
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
237
625
3.86
78.23
1.4
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
799
4057
2.06
73.71
6.9
9.2
mmol/l
24.6
24.5
0.69
763
3711
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
201
494
4.14
73.12
1.3
1.4
u/l
11.0
13.2
6.44
193
474
(3020891) Body temperature
704
3427
2.14
72.59
4.9
5.0
—
—
—
0
0
(44806118)
251
733
3.49
71.26
1.3
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1438
8902
1.73
71.19
1.7
1.9
—
—
—
0
0
(44790049)
251
734
3.49
71.11
1.3
1.4
—
—
—
0
0
(44790048)
251
734
3.49
71.11
1.3
1.4
—
—
—
0
0
(44790047)
251
734
3.49
71.11
1.3
1.4
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
125
210
6.02
70.94
1.3
2.6
e6/l
4179.1
556.2
0.55
85
153
(1761868) Lipid panel - Serum or Plasma
1682
24702
0.61
69.85
2.6
3.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
171
387
4.48
69.25
3.5
4.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
94
120
7.90
68.79
1.6
2.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
180
430
4.25
68.01
1.7
1.9
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
626
2992
2.17
67.52
3.9
4.3
mmol/l
1.5
1.4
0.87
611
2934
(3024354) Oxygen [Partial pressure] in Venous blood
1102
6418
1.81
67.10
3.3
3.2
kpa
4.5
4.5
0.04
1052
6209
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
113
182
6.27
66.91
1.3
2.4
e6/l
16950.8
20786.5
0.10
66
95
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
260
816
3.25
65.83
1.4
2.6
u/ml
811.8
11110.0
0.47
11
51
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
146
308
4.80
64.47
1.5
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
146
308
4.80
64.47
1.5
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
146
308
4.80
64.47
1.5
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
994
5679
1.84
64.29
4.1
4.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
146
309
4.78
64.22
1.5
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
948
5348
1.86
63.84
3.3
3.6
kpa
5.1
5.1
1.18
872
4924
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
673
12459
0.50
63.36
1.2
1.3
u/ml
22.0
14.5
0.57
260
4574
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
910
5089
1.87
62.95
3.3
3.5
mmol/l
2.1
1.8
1.38
671
3744
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
439
1870
2.41
62.13
1.8
2.1
%
89.9
89.5
0.11
431
1735
(3052851) Hemolysis interference index of Serum or Plasma
509
2314
2.27
62.00
4.0
3.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
711
3685
2.01
61.62
3.5
4.2
mmol/l
24.1
24.2
0.05
663
3256
(3008152) Bicarbonate [Moles/volume] in Arterial blood
941
5355
1.84
61.52
6.2
7.2
mmol/l
24.7
24.6
0.41
887
4977
(3009343) pH of Capillary blood
930
5275
1.85
61.44
3.3
3.6
ph
7.4
7.4
0.57
155
654
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
75
84
8.99
60.99
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
744
13203
0.53
60.96
1.2
1.3
iu/ml
47.0
38.1
0.69
218
4099
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
120
227
5.34
60.08
1.6
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
119
225
5.34
59.62
1.6
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
119
225
5.34
59.62
1.6
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
98
154
6.42
59.46
1.5
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
2187
29501
0.66
58.71
3.8
4.1
mg/mmol
12.7
9.0
2.53
1398
18797
(3023323) Follitropin [Units/volume] in Serum or Plasma
395
1653
2.45
58.09
1.7
1.3
iu/l
31.7
33.4
0.45
334
1429
(3012516) Albumin [Mass/volume] in Urine
2059
27929
0.66
56.10
3.1
3.3
mg/l
711.6
297.2
2.64
1337
17832
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
404
1738
2.38
55.88
1.9
2.4
%
232.5
193.4
11.24
389
1638
(3028626) Oxygen [Partial pressure] in Capillary blood
414
1805
2.35
55.55
2.6
3.1
kpa
8.0
7.9
0.43
384
1674
(3044007) Cell count panel - Peritoneal fluid
97
168
5.82
53.40
1.4
2.5
—
—
—
0
0
(3013512) EKG study
3197
24974
1.42
52.96
4.3
4.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
3378
26658
1.42
52.79
3.0
3.1
ng/l
1387.7
1489.3
0.56
3062
23032
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
71
90
7.94
52.29
1.3
1.4
%
14.0
9.3
0.72
50
44
(3009508) Creatinine [Moles/volume] in Urine
2138
28462
0.68
51.71
2.9
3.2
mmol/l
7.3
7.5
1.14
1690
23779
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
6483
71526
0.70
51.57
5.8
4.7
mu/l
3.0
2.1
1.01
5786
64628
(3021162) Amylase [Enzymatic activity/volume] in Specimen
57
57
10.05
50.39
2.5
2.2
u/l
1611.7
4614.7
0.48
47
49
(3021901) Oxygen saturation in Capillary blood
359
1540
2.38
49.95
2.6
2.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
1105
6998
1.66
48.85
2.8
2.2
e9/l
72.8
69.0
2.16
851
5346
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
94
172
5.51
48.85
1.2
1.3
ug/l
584.2
59.9
3.31
72
75
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
264
995
2.70
48.19
5.3
6.5
mg/l
11.5
12.0
1.17
237
902
(3041096) Erythrocytes [Presence] in Urine by Automated
2570
19573
1.43
47.96
4.5
3.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
91
167
5.49
47.15
1.1
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
116
263
4.45
46.96
1.8
2.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
1720
12175
1.50
46.70
16.2
29.0
inr
1.3
1.5
6.03
290
1663
(3017143) Hepatitis C virus Ab [Presence] in Serum
944
5813
1.69
46.33
1.4
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
723
4127
1.81
46.31
7.8
10.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
546
2849
1.97
46.14
2.5
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
507
2583
2.02
45.85
4.1
4.6
mmol/l
3.9
3.9
0.36
478
2439
(3000570) Elastase.pancreatic [Mass/mass] in Stool
456
2238
2.09
45.65
1.4
1.4
ug/g
214.0
284.1
10.92
311
1324
(3018834) Bilirubin.total [Presence] in Urine by Test strip
31
12
25.91
44.47
6.2
1.3
estimate
0.0
—
—
9
0
(21494815) CD4 cells/100 lymphocytes in Specimen
131
340
3.89
44.33
1.7
2.1
%
35.2
45.0
—
6
49
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
67
3162
0.21
44.17
1.4
1.5
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
119
289
4.16
44.09
1.6
2.0
%
69.7
71.9
0.74
114
274
(3036489) Thrombin time
494
2537
2.00
43.65
1.7
1.9
s
22.0
21.5
0.73
456
2223
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1001
6353
1.64
43.61
1.4
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
116
283
4.14
42.73
1.6
2.0
%
17.6
16.5
0.14
18
121
(3011412) CD3 cells [#/volume] in Blood
139
389
3.61
42.20
1.6
2.1
e9/l
0.9
1.0
1.57
106
215
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
44
39
11.33
42.19
2.6
1.0
ug/l
19.0
1.5
0.96
31
17
(44786800) Granulocytes/100 leukocytes in Body fluid
57
73
7.85
41.63
1.2
1.3
%
19.7
22.6
0.22
46
55
(3003181) Sodium [Moles/volume] in Urine
318
1405
2.31
41.35
1.3
1.3
mmol/l
60.9
65.4
1.06
238
1127
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
186
4817
0.37
40.96
1.5
1.9
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
723
4299
1.74
40.10
3.7
3.3
mmol/l
25.2
25.2
0.01
707
4171
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3566
29324
1.35
39.93
4.9
4.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
429
2179
2.01
39.08
2.8
3.0
mmol/l
24.9
24.7
0.16
360
1918
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
81
159
5.13
39.00
1.3
1.4
%
21.5
26.1
0.65
71
131
(3019550) Sodium [Moles/volume] in Serum or Plasma
8597
81428
1.63
38.63
37.9
16.6
mmol/l
138.4
139.8
307.65
8438
79251
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1052
15364
0.65
38.02
1.2
1.2
u/ml
1.4
1.8
0.99
291
4020
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
97
226
4.33
37.99
2.5
2.5
%
41.4
42.5
0.10
16
79
(3023103) Potassium [Moles/volume] in Serum or Plasma
8600
81619
1.61
36.42
38.1
16.7
mmol/l
4.0
4.0
0.16
8432
79319
(3009261) Glucose [Presence] in Urine by Test strip
4500
38609
1.32
36.31
4.6
3.7
estimate
0.0
0.0
2.04
1309
6343
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
167
578
2.92
35.85
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
613
3618
1.74
34.80
1.2
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
4436
38126
1.31
34.72
5.7
4.9
estimate
0.0
0.0
0.80
1319
6567
(3014891) Appearance of Pleural fluid
61
103
5.95
34.54
1.7
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
643
3863
1.71
34.24
1.3
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
661
4015
1.69
33.79
2.8
2.8
%
1.2
1.2
0.39
656
3993
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
45
57
7.93
33.18
1.3
2.5
%
51.6
64.7
0.99
28
36
(3004119) Hemoglobin [Mass/volume] in Venous blood
817
5270
1.60
32.92
3.3
3.3
g/l
117.4
130.5
48.87
807
5130
(3024522) Salmonella sp identified in Specimen by Organism specific culture
220
917
2.43
32.69
1.5
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
219
911
2.44
32.68
1.5
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
645
3929
1.69
32.60
2.9
2.8
%
0.7
0.7
3.20
635
3752
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
526
3029
1.78
32.50
2.0
2.4
ug/l
241.1
692.8
4.67
500
2851
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
656
4021
1.68
32.38
5.0
3.0
pmol/l
4.3
4.4
3.28
601
3522
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
222
943
2.39
31.65
1.5
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
325
1615
2.05
31.45
1.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
214
900
2.41
31.19
1.5
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
214
901
2.41
31.12
1.5
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
214
903
2.40
30.97
1.5
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2117
16615
1.35
30.43
4.1
4.0
ng/l
182.9
592.7
10.05
1736
13731
(3035350) Ketones [Presence] in Urine by Test strip
4396
38137
1.29
30.42
4.5
3.7
estimate
0.0
0.0
0.50
1317
6463
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
106
311
3.44
30.06
1.7
2.1
e6/l
494.8
720.0
1.73
25
141
(3043410) Blood group antigens tested for on Red Blood Cells
78
185
4.24
29.92
2.2
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
56
2303
0.24
29.60
1.7
1.7
mg/l
5.9
3.7
0.77
47
1625
(3037692) Legionella sp identified in Specimen by Organism specific culture
87
227
3.86
29.34
1.0
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
196
4335
0.44
29.30
1.1
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
244
1125
2.20
28.71
1.4
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2089
16533
1.34
28.04
1.7
1.7
mg/l
2.5
1.2
20.27
1766
12747
(3026692) Albumin [Mass/volume] in Peritoneal fluid
72
170
4.26
27.81
1.1
1.7
g/l
13.0
13.9
0.35
57
128
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
174
702
2.51
27.79
3.7
1.7
u/l
16.1
2181.9
4.04
71
265
(3022313) Gas panel - Capillary blood
611
3828
1.64
27.62
3.6
3.7
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
343
1821
1.92
27.49
3.3
2.9
mg/l
1.4
1.7
12.32
321
1625
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
176
719
2.48
27.38
2.7
2.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
191
810
2.39
27.38
3.5
3.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
129
453
2.87
27.08
1.6
1.3
nmol/l
0.2
0.3
2.16
75
346
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
128
449
2.88
26.92
1.9
1.5
u/l
6.4
6.9
0.11
76
196
(1002224) Polysomnography panel
79
2527
0.31
26.77
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
303
5589
0.53
26.62
1.1
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
176
750
2.37
24.99
1.5
1.2
u/l
140.6
56.9
2.21
127
476
(3037522) Nuclear Ab [Titer] in Serum
692
10190
0.65
24.89
1.2
1.3
titre
409.2
541.8
2.03
139
2271
(3042010) Triglyceride [Moles/volume] in Pleural fluid
49
92
5.35
24.88
1.2
1.2
mmol/l
0.8
1.7
0.52
40
53
(3045142) Bone marrow Pathology biopsy report
142
549
2.61
24.81
1.2
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
528
3303
1.63
23.98
3.7
3.9
mmol/l
25.1
24.9
0.76
481
3030
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
523
8118
0.62
23.90
1.5
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
127
476
2.69
23.63
1.3
1.3
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
30
35
8.59
23.62
7.8
1.2
pmol/l
1510.9
1.5
—
19
9
(3044889) 12 lead EKG panel
6149
56409
1.26
23.59
4.6
4.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
428
2553
1.71
23.33
4.7
6.1
mmol/l
1.3
1.3
0.01
376
2267
(3021387) Prolactin [Units/volume] in Serum or Plasma
260
1334
1.98
23.08
1.5
1.8
mu/l
333.5
307.1
0.82
254
1219
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
124
468
2.67
22.77
1.3
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
301
1636
1.87
22.49
1.4
1.7
iu/l
2.9
4.4
4.40
74
557
(3002331) Protein [Mass/volume] in Peritoneal fluid
59
145
4.09
21.69
1.1
1.5
g/l
23.8
65.9
0.52
48
112
(40765096) Chromosome analysis panel by Banding
50
108
4.65
21.65
1.1
1.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
71
202
3.53
21.22
1.2
2.1
u/ml
90.0
54615.0
—
5
32
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
5395
58692
0.81
21.00
5.4
3.8
pmol/l
15.1
14.9
6.41
4876
52643
(3006184) Hemoglobin [Mass/volume] in Capillary blood
334
1916
1.77
20.93
2.4
2.2
g/l
120.3
131.1
10.72
263
1384
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
778
10845
0.69
20.78
3.5
5.0
%
31.1
32.7
3.83
521
7263
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
96
335
2.88
20.49
1.4
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
96
335
2.88
20.49
1.4
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
5227
47456
1.23
20.41
4.1
3.0
u/l
103.6
48.8
61.93
4872
43349
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3138
36025
0.81
20.27
1.8
2.0
pmol/l
86.7
94.7
19.59
1955
18557
(3002385) Erythrocyte distribution width [Ratio]
6647
61942
1.25
20.14
46.7
16.3
%
15.1
13.7
307.65
6577
60414
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
74
226
3.29
19.84
3.3
2.3
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
32
51
6.29
19.24
1.3
2.4
%
23.1
12.1
0.72
15
29
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
878
6439
1.40
18.46
5.3
2.5
ml/min/173m2
62.5
62.5
0.01
382
2530
(3008898) HLA-B27 [Presence]
71
1954
0.36
17.83
1.0
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
0
+∞
17.71
1.1
0.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
1056
8038
1.35
17.61
1.3
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
280
1607
1.76
17.57
1.2
1.2
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
97
372
2.62
17.37
1.2
1.1
u/l
116.5
85.4
1.08
88
285
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
96
370
2.61
17.03
1.2
1.1
u/l
61.0
22.6
1.89
83
275
(3008295) Osmolality of Serum or Plasma
151
714
2.13
16.85
1.3
1.4
mosm/kgh2o
272.3
277.5
2.28
131
543
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
524
3549
1.50
16.79
4.7
4.9
%
1.6
1.6
0.24
491
3341
(3005322) IgE [Units/volume] in Serum or Plasma
250
4258
0.58
16.50
1.3
1.3
u/ml
367.9
238.0
0.61
226
3918
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
81
291
2.80
16.47
2.5
2.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
579
8177
0.69
16.40
2.0
2.1
ug/g
243.0
144.5
3.27
469
6344
(3007930) Methemoglobin/Hemoglobin.total in Blood
516
3504
1.50
16.33
4.7
5.0
%
0.9
0.9
0.06
484
3297
(3001019) Free T4 and TSH panel - Serum or Plasma
112
2447
0.45
16.22
1.8
1.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
42
100
4.21
16.17
2.5
2.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
8514
82334
1.35
16.03
29.7
9.5
u/l
26.7
25.8
3.60
8360
78691
(40761539) Cells [Type] in Urine sediment by Light microscopy
56
165
3.41
15.96
1.7
1.1
—
—
—
0
0
(40758358) Immune stain study
15
0
+∞
15.62
1.0
0.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
3050
26721
1.21
15.57
2.5
2.2
u/l
177.6
229.5
2.66
2884
24900
(3041918) Cholesterol [Moles/volume] in Pleural fluid
50
139
3.61
15.56
1.2
1.2
mmol/l
1.8
1.4
2.22
41
74
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
89
348
2.57
15.38
2.0
1.4
mg/l
4.1
4.0
0.04
83
330
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
547
3808
1.46
15.29
1.4
1.5
g/l
2.0
1.5
15.10
458
3236
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
30
57
5.28
15.10
1.9
1.2
ng/l
81.6
104.2
—
7
17
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1026
7953
1.33
15.02
2.8
3.1
ng/l
162.6
221.5
4.56
944
7322
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
19
6
31.72
14.78
1.1
1.0
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
36
84
4.30
14.25
1.3
1.3
u/l
39.8
421.5
0.47
30
55
(3015736) pH of Urine
3354
29821
1.19
14.25
4.1
3.5
ph
5.8
5.3
—
20
10
(40761511) CBC panel - Blood by Automated count
8223
79388
1.28
13.75
32.0
13.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
46
132
3.50
13.70
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
181
985
1.85
13.63
1.4
1.3
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
20
28
7.16
13.53
1.3
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
261
1588
1.66
13.33
1.3
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
55
180
3.07
13.28
1.1
1.5
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
32
72
4.46
13.27
1.1
1.1
u/l
26.3
16.2
1.22
26
45
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
175
951
1.86
13.25
1.2
1.1
g/l
1.6
1.5
2.74
161
835
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
301
4638
0.64
13.14
1.2
1.3
au/ml
44.5
49.0
0.09
11
194
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
32
73
4.39
13.05
1.2
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1033
12923
0.77
13.02
1.4
1.3
g/l
2.5
2.6
0.70
643
7328
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
342
5112
0.66
12.93
2.3
2.4
au/ml
23.4
27.1
0.11
11
204
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
194
1097
1.78
12.92
1.2
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
268
1662
1.63
12.72
1.4
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
74
292
2.55
12.63
1.1
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
30
67
4.49
12.57
1.1
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
72
1682
0.42
12.49
1.3
1.2
—
19.8
—
0
21
(40761535) Cells panel - Urine sediment
904
7073
1.31
12.30
4.0
3.4
—
—
—
0
0
(3039000) Anion gap in Blood
283
1805
1.59
11.99
5.8
7.0
mmol/l
10.9
11.3
1.67
253
1627
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
175
3005
0.57
11.96
1.3
1.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
283
1806
1.58
11.96
5.8
7.0
mmol/l
104.3
104.8
0.83
253
1628
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
106
2111
0.50
11.90
1.3
1.2
u/ml
26.0
40.2
—
7
133
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
49
162
3.04
11.68
1.5
1.1
ug/l
2.0
2.6
0.45
23
120
(3013139) Helicobacter pylori Ag [Presence] in Stool
361
5228
0.68
11.63
1.2
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
87
385
2.27
11.58
2.0
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
207
3350
0.61
11.22
1.3
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
98
1960
0.49
11.17
1.3
1.3
u/ml
2.7
4.8
2.11
22
322
(4094501)
129
2354
0.54
10.98
1.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
91
421
2.17
10.90
1.2
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
211
3374
0.62
10.88
1.0
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
98
1936
0.50
10.78
1.3
1.3
u/ml
1.7
8.5
1.67
15
206
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
88
1802
0.48
10.77
1.1
1.1
u/ml
5.6
9.6
—
5
162
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
186
1099
1.71
10.70
1.2
1.4
—
15.8
—
0
26
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
38
114
3.34
10.64
4.3
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
62
1431
0.43
10.51
1.8
1.8
pmol/l
147.6
195.7
3.48
55
1341
(40760888) Immunoglobulin light chains.free panel - Serum
297
1976
1.52
10.47
3.9
1.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
32
87
3.69
10.38
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3661
39913
0.86
10.28
2.5
2.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
6021
63351
0.86
10.24
48.7
18.0
g/l
328.9
332.3
149.54
5959
62880
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
91
433
2.11
10.18
1.8
1.2
u/l
111.4
88.3
0.89
84
371
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
27
66
4.10
10.13
1.0
1.1
iu/ml
18.6
10.1
0.24
14
21
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
88
415
2.13
10.08
2.0
2.0
u/field
2.3
2.7
0.29
68
279
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
9
474
0.19
10.02
1.0
1.1
—
0.2
—
0
116
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
167
979
1.72
9.92
1.2
1.5
u/ml
111.3
117.6
0.32
37
201
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
138
2391
0.57
9.81
1.5
1.7
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
18
32
5.63
9.73
1.0
1.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
87
417
2.10
9.58
1.9
1.2
u/l
48.0
21.1
2.57
77
350
(44816559) Phosphatidylethanol [Mass/volume] in Blood
51
1224
0.41
9.57
1.2
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
167
990
1.70
9.54
1.1
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
81
379
2.15
9.49
2.2
2.0
ml
1729.0
1909.3
0.81
72
329
(3040151) Glucose [Moles/volume] in Capillary blood
163
966
1.70
9.33
5.2
14.3
mmol/l
7.3
7.5
0.31
145
789
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
81
1617
0.50
9.26
1.2
1.2
u/ml
1.1
6.7
—
8
133
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
19
725
0.26
9.14
1.0
1.0
ng/l
773.6
708.5
0.26
11
471
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7559
72967
1.18
9.12
40.7
12.6
ml/min/173m2
79.4
76.0
40.14
7043
58961
(3020961) Endomysium IgA Ab [Titer] in Serum
201
3114
0.64
9.06
1.1
1.1
titre
181.7
189.6
—
6
84
(1761482) Bacteria [#/volume] in Urine by Culture
330
2315
1.44
8.97
5.2
4.0
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
20
728
0.27
8.88
1.0
1.0
ng/l
37.0
44.5
0.33
12
483
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
20
721
0.28
8.73
1.1
1.0
ng/l
460.5
341.7
0.34
14
487
(3007566) Smooth muscle Ab [Titer] in Serum
280
1914
1.48
8.72
1.2
1.2
titre
79.1
141.7
1.17
23
165
(3017732) Neutrophils [#/volume] in Blood
659
5183
1.29
8.62
5.9
2.9
e9/l
4.2
4.1
0.72
557
3757
(3015171) Extractable nuclear Ab [Units/volume] in Serum
195
2994
0.64
8.46
1.1
1.2
u/ml
2.3
0.8
0.34
15
277
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
364
2629
1.40
8.43
4.0
1.6
ratio
1.4
2.4
1.40
25
210
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
84
419
2.01
8.37
1.7
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
32
885
0.36
8.36
1.1
1.1
u/ml
0.2
1.1
—
10
349
(3003888) Timothy IgE Ab [Units/volume] in Serum
26
785
0.33
8.16
1.0
1.1
u/ml
0.5
3.1
6.77
11
360
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
27
78
3.47
8.07
1.0
2.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
91
475
1.92
7.98
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
25
760
0.33
7.96
1.1
1.1
u/ml
0.1
0.8
—
8
301
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
76
1469
0.51
7.93
1.2
1.2
u/ml
39.4
44.8
0.11
12
161
(3028433) Virus identified in Specimen by Culture
54
231
2.35
7.90
1.1
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
46
183
2.52
7.87
1.7
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1962
22054
0.86
7.81
3.0
2.5
umol/l
2432.9
5591.0
2.58
1687
18727
(3016650) Hepatitis A virus Ab [Presence] in Serum
155
954
1.64
7.76
1.1
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
75
1445
0.52
7.76
1.6
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
80
404
1.99
7.73
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
80
405
1.98
7.68
1.1
1.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
369
2718
1.37
7.63
4.1
1.6
mg/l
47.7
47.9
0.01
300
2192
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
368
2712
1.37
7.58
4.1
1.6
mg/l
72.8
37.7
0.53
297
2179
(46235355) HIV 1 and 2 tests - Meaningful Use set
910
7555
1.23
7.47
1.3
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
293
2084
1.42
7.45
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
295
2102
1.42
7.43
1.2
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
39
149
2.62
7.26
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
295
2111
1.41
7.26
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
182
2741
0.66
7.26
1.3
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
44
991
0.44
7.15
1.1
1.0
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
11
16
6.88
7.14
1.5
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
270
1912
1.42
7.06
1.2
1.2
titre
355.7
1014.8
—
7
62
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
32
112
2.86
7.03
1.1
1.1
pmol/l
6.2
4.3
—
8
8
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3320
30640
1.13
7.03
2.4
2.8
ug/l
398.8
137.1
49.73
3069
27992
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
78
1436
0.54
7.00
1.4
1.7
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
112
652
1.73
6.96
2.2
2.2
u/field
3.1
1.9
1.01
59
247
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
55
1130
0.48
6.96
1.3
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
79
413
1.92
6.96
1.5
1.8
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
34
126
2.70
6.74
2.3
1.4
u/l
44.9
41.0
0.05
34
113
(3020876) Protein [Mass/time] in 24 hour Urine
116
694
1.68
6.55
1.9
1.8
—
1.3
—
0
39
(3037756) Immunofixation for Serum or Plasma
236
1657
1.44
6.50
1.8
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
685
8318
0.81
6.47
1.4
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
978
8306
1.20
6.35
2.3
2.4
ug/l
4.4
8.0
10.86
857
7249
(3010370) Gastrin [Moles/volume] in Serum or Plasma
25
81
3.09
6.30
1.7
1.5
pmol/l
51.0
55.0
0.06
20
68
(3006922) Hepatitis E virus Ab [Presence] in Serum
80
436
1.84
6.25
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
146
2226
0.65
6.23
1.6
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
149
2260
0.65
6.21
1.4
1.6
iu/ml
0.1
2.6
0.91
42
494
(3019977) pH of Arterial blood
86
482
1.79
6.14
1.8
2.4
ph
7.4
7.4
0.59
27
176
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
176
2573
0.68
6.10
1.3
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
7
316
0.22
6.09
1.1
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
166
1104
1.51
6.05
2.9
2.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
32
122
2.63
6.04
1.4
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
87
493
1.77
6.00
2.7
3.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
37
153
2.42
5.92
1.2
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
155
2307
0.67
5.90
1.5
1.6
e6/l
13365.5
14015.0
0.09
118
1676
(3000093) Morphology [Interpretation] in Blood Narrative
115
707
1.63
5.90
1.2
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
29
710
0.41
5.89
1.7
2.0
ug/l
2.1
2.4
0.36
23
590
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
292
3887
0.74
5.80
1.2
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
52
1020
0.51
5.80
1.3
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
31
731
0.42
5.75
1.6
1.9
ug/l
3.4
3.7
0.10
22
644
(3000494) Fungus identified in Specimen by Culture
1043
8989
1.18
5.73
1.4
1.4
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
92
538
1.72
5.71
1.1
1.1
mmol/l
38.6
33.8
1.30
79
450
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
26
92
2.83
5.65
1.2
1.6
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
16
42
3.81
5.53
1.1
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
36
777
0.46
5.34
1.0
1.1
u/ml
2.7
3.6
—
7
301
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
50
249
2.01
5.16
1.4
1.3
umol/l
28.1
29.6
0.57
50
238
(3005719) IgG [Mass/volume] in Serum or Plasma
596
4932
1.22
5.10
2.3
2.3
g/l
10.0
10.9
3.45
522
4497
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
55
285
1.94
5.08
1.7
2.1
e6/l
483.5
438.8
0.31
45
246
(3016273) Islet cell 512 Ab [Units/volume] in Serum
12
27
4.45
5.03
1.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
17
50
3.40
5.02
1.5
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
8625
84897
1.19
5.00
55.1
20.1
e9/l
252.2
243.5
21.23
8422
82173
(3035941) MCH [Entitic mass]
8625
84921
1.18
4.85
54.8
20.0
pg
30.3
30.5
7.93
8480
83366
(3009542) Hematocrit [Volume Fraction] of Blood
6927
67272
1.11
4.81
34.8
15.1
%
36.1
39.5
131.93
4267
43866
(3024731) MCV [Entitic volume]
8625
84928
1.18
4.81
54.8
20.0
fl
92.1
91.5
25.29
8478
83371
(3010813) Leukocytes [#/volume] in Blood
8626
84941
1.18
4.79
55.0
20.1
e9/l
6.9
6.7
9.78
8407
81898
(3044941) Cell count panel - Synovial fluid
91
1445
0.63
4.78
1.2
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
282
3663
0.76
4.77
2.2
1.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
8625
84935
1.18
4.76
55.0
20.1
e12/l
4.1
4.5
307.65
8406
81883
(3000963) Hemoglobin [Mass/volume] in Blood
8625
84946
1.18
4.70
55.3
20.2
g/l
121.6
136.3
307.65
8475
83409
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
232
0.22
4.67
1.8
1.6
ug/l
16.3
8.9
—
5
232
(44813793)
18
486
0.37
4.66
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
500
4105
1.23
4.65
1.2
1.2
iu/ml
139.8
134.6
0.08
110
1534
(3023419) Bacteria identified in Sputum by Culture
157
1099
1.44
4.53
1.7
2.4
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
25
578
0.43
4.51
1.2
1.1
—
36.8
—
0
5
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
638
7523
0.84
4.48
1.6
1.7
%
1.6
1.5
1.11
515
6388
(40768797) Stomach Pathology biopsy report
1233
10976
1.14
4.40
1.3
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
232
1745
1.34
4.36
1.9
3.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
137
942
1.46
4.36
1.8
1.3
nmol/l
—
—
—
0
0
(4010399)
524
6264
0.83
4.28
1.3
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
205
2739
0.74
4.28
1.7
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
18
62
2.91
4.16
1.8
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
5650
58460
0.92
4.12
3.4
4.2
mm/h
23.1
12.4
179.95
5069
53705
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
249
0.28
4.12
1.3
1.5
—
—
—
0
0
(3000492) Spirometry study
570
6736
0.84
4.12
1.4
1.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
23
91
2.53
4.12
3.6
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
717
6169
1.18
4.06
3.0
3.9
ng/l
100.0
95.5
0.46
625
5246
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
105
701
1.50
3.91
1.4
1.6
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
42
770
0.54
3.91
1.1
1.4
—
24.8
—
0
37
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
101
1496
0.67
3.90
1.3
1.5
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
10
24
4.17
3.88
1.4
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
34
165
2.06
3.84
2.0
2.9
—
—
—
0
0
(4146454)
69
1103
0.62
3.82
2.4
2.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
118
812
1.46
3.80
2.2
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
19
454
0.42
3.78
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
43
774
0.55
3.77
1.9
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
139
990
1.41
3.72
1.8
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
138
1914
0.72
3.71
2.5
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
146
2005
0.72
3.70
1.8
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
62
373
1.67
3.61
1.1
1.1
—
—
—
0
0
(4034850)
223
2867
0.77
3.58
15.0
10.6
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
17
62
2.74
3.58
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
17
62
2.74
3.58
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
17
62
2.74
3.58
1.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
61
985
0.62
3.55
1.8
1.7
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
248
0.32
3.55
5.9
7.6
—
—
—
0
0
(4024509)
49
835
0.58
3.54
1.7
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
63
1008
0.62
3.53
1.8
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
54
316
1.71
3.49
1.2
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
54
316
1.71
3.49
1.2
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
29
573
0.50
3.48
1.2
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
63
1004
0.62
3.47
1.7
1.7
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
213
0.28
3.46
5.5
7.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
31
598
0.52
3.45
1.6
1.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
46
258
1.79
3.45
1.7
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
46
258
1.79
3.45
1.7
2.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
64
1012
0.63
3.42
1.8
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
121
1688
0.71
3.41
1.4
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
30
146
2.06
3.40
1.8
2.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
80
521
1.54
3.39
1.1
1.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
12
330
0.36
3.34
1.1
1.1
—
4.2
—
0
53
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
146
1073
1.37
3.29
1.8
1.3
nmol/l
1.9
3.1
0.28
140
1027
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
42
729
0.57
3.28
1.3
1.7
u/ml
48.5
24.4
1.79
13
170
(3013637) Mi-2 Ab [Presence] in Serum
8
240
0.33
3.28
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
240
0.33
3.28
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
240
0.33
3.28
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
240
0.33
3.28
1.1
1.1
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
15
54
2.78
3.25
1.5
1.4
ml/s/173m2
1.7
0.7
—
7
34
(3016018) Differential panel - Cerebral spinal fluid
105
731
1.44
3.24
1.5
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
26
518
0.50
3.22
1.5
1.3
u/ml
3.5
1.0
0.35
16
270
(3004588) Protein electrophoresis panel - Serum or Plasma
678
5931
1.15
3.15
2.8
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
149
1108
1.35
3.14
1.6
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
52
312
1.67
3.11
1.2
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
460
3911
1.19
3.08
1.6
1.5
g/l
1.0
1.2
2.18
405
3537
(3016879) Cocaine [Presence] in Urine
60
936
0.64
3.06
1.8
1.7
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
68
442
1.54
2.96
1.6
2.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
30
155
1.94
2.93
1.2
1.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
24
472
0.51
2.90
1.5
1.4
u/l
17.6
5.8
0.92
19
393
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
18
76
2.37
2.88
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
15
349
0.43
2.88
1.3
1.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
46
274
1.68
2.85
1.7
2.1
e9/l
0.2
0.2
0.06
41
244
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
85
1216
0.70
2.83
1.5
1.5
%
68.8
59.8
1.62
55
780
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
143
1076
1.33
2.82
1.8
1.3
nmol/l
0.6
0.3
0.37
17
81
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
29
531
0.54
2.80
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
29
530
0.55
2.78
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
29
529
0.55
2.76
1.0
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
50
308
1.63
2.75
1.7
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
177
2256
0.78
2.74
1.2
1.5
g/l
1.2
1.2
1.33
161
2128
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
29
526
0.55
2.72
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
29
526
0.55
2.72
1.0
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3028
31769
0.93
2.70
2.1
2.2
nmol/l
76.8
78.6
2.63
2787
27836
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
10
6.00
2.69
1.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
29
524
0.55
2.69
1.0
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
7
198
0.35
2.65
1.1
1.0
—
0.2
—
0
28
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
198
0.35
2.65
1.9
1.6
ng/l
188.7
119.2
—
7
198
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
403
4707
0.85
2.64
2.5
2.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
239
2928
0.81
2.63
1.4
1.6
titre
136.7
305.7
—
6
142
(3011288) Drugs identified in Urine by Screen method
38
632
0.60
2.60
2.1
2.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
135
1022
1.33
2.59
1.3
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
36
605
0.59
2.57
1.2
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
318
0.44
2.57
1.1
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
349
2950
1.19
2.55
1.2
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
62
410
1.52
2.54
3.1
4.0
—
—
—
0
0
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
6
11
5.46
2.54
2.2
3.6
mg/l
5.3
4.8
—
6
5
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
15
62
2.42
2.53
1.2
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
58
380
1.53
2.49
1.1
1.1
iu/ml
—
4.6
—
0
26
(3009445) Proteinase 3 Ab [Units/volume] in Serum
314
3723
0.84
2.47
1.2
1.5
u/ml
30.5
16.0
—
5
86
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
57
373
1.53
2.46
1.3
1.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
20
96
2.09
2.42
1.0
1.1
—
—
—
0
0
(3036603) Volume of Urine
72
499
1.45
2.37
2.0
1.4
ml
2060.5
1994.7
0.12
31
118
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
174
1381
1.26
2.37
2.6
3.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
140
1081
1.30
2.36
2.5
1.3
mu/l
68.9
61.2
0.17
126
958
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
177
2210
0.80
2.35
1.2
1.6
g/l
0.3
0.2
1.61
163
2091
(3048929) Epstein Barr virus Ab [Presence] in Serum
178
1418
1.26
2.35
1.2
1.2
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
10
35
2.86
2.30
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
34
561
0.60
2.29
1.1
1.1
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
6
13
4.62
2.27
3.5
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
7
18
3.89
2.25
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
32
186
1.72
2.23
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
135
1047
1.29
2.23
1.1
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
77
548
1.41
2.22
1.4
2.2
min
501.6
501.1
0.01
45
415
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
833
9151
0.90
2.18
1.3
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
13
280
0.46
2.12
1.8
1.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
25
3.20
2.09
1.4
3.5
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
25
3.20
2.09
2.8
7.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
9
31
2.90
2.07
2.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
43
654
0.66
2.06
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
31
184
1.69
2.03
1.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
300
0.50
2.00
1.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
300
0.50
2.00
1.1
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
299
0.50
1.99
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
299
0.50
1.99
1.1
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
13
57
2.28
1.97
1.2
1.2
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
5
11
4.55
1.94
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
5
11
4.55
1.94
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
5
11
4.55
1.94
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
5
11
4.55
1.94
1.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
70
960
0.73
1.93
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
13
59
2.20
1.84
1.2
1.2
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
6
17
3.53
1.83
1.0
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
84
1110
0.75
1.83
3.3
4.5
umol/l
330.6
355.2
0.98
75
913
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
124
980
1.27
1.83
1.1
1.2
u/ml
295.7
288.6
0.12
89
630
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
169
0.41
1.77
1.1
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1834
17391
1.07
1.76
4.8
4.2
kg/l
1.0
1.0
0.01
273
2635
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
143
1757
0.81
1.73
1.4
1.3
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
7
24
2.92
1.72
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
68
914
0.74
1.69
1.1
1.2
%
116.8
115.0
0.14
58
822
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
50
706
0.71
1.69
1.1
1.2
%
90.5
94.2
0.50
44
659
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
267
0.52
1.66
1.1
1.1
miu/ml
1800.2
1641.6
0.15
14
267
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
21
119
1.77
1.65
1.0
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
127
1021
1.25
1.65
2.1
1.3
pmol/l
244.0
266.1
0.28
92
768
(4306422)
71
944
0.75
1.65
1.2
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
225
0.49
1.62
1.5
1.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
55
756
0.73
1.60
1.1
1.2
nmol/l
315.5
337.7
0.34
40
612
(3010144) Erythrocytes [#/volume] in Synovial fluid
69
914
0.75
1.57
1.4
1.3
e6/l
79271.6
157470.8
1.04
52
623
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
16
286
0.56
1.55
1.1
1.4
—
—
—
0
0
(4268621)
47
658
0.71
1.54
2.3
2.3
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
8
33
2.43
1.53
1.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
14
259
0.54
1.53
1.1
1.4
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
43
0.00
1.52
0.0
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
70
918
0.76
1.50
1.2
1.2
mmol/l
8.2
7.7
0.72
55
632
(3019309) Folate [Moles/volume] in Red Blood Cells
1801
17170
1.06
1.46
1.8
1.8
nmol/l
1274.9
1152.1
5.08
1398
12888
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
3486
33822
1.05
1.45
11.2
4.0
ug/l
26.2
2.3
16.83
3126
30258
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
9
38
2.37
1.45
4.8
1.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
19
316
0.60
1.43
1.6
1.8
ug/l
14.4
441.0
1.20
19
293
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
93
1168
0.79
1.43
1.1
1.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
42
295
1.43
1.41
1.6
1.7
nmol/l
15.3
5.3
0.98
37
245
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
7
29
2.41
1.39
1.3
1.0
nmol/l
273.9
253.2
—
7
29
(3004446) Plasmodium sp identified in Blood by Light microscopy
11
53
2.08
1.38
2.6
2.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
14
249
0.56
1.36
1.1
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
48
348
1.38
1.36
2.1
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
14
248
0.56
1.35
1.1
1.4
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
38
0.00
1.34
0.0
1.3
—
89.4
—
0
33
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
68
878
0.77
1.33
1.5
1.5
%
16.4
29.5
3.93
43
564
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
192
1.51
1.31
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
23
356
0.65
1.30
1.0
1.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
279
2466
1.14
1.29
2.8
1.5
g/l
0.1
0.0
0.48
249
2233
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
46
623
0.74
1.27
1.1
1.2
titre
80.0
162.2
1.62
12
111
(3034891) Synovial lining cells/100 cells in Synovial fluid
30
437
0.69
1.27
1.5
1.5
%
4.3
3.8
—
9
100
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
27
401
0.67
1.26
1.3
1.4
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
9
44
2.05
1.26
5.2
5.0
g/mol
31.8
62.1
—
9
37
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
35
244
1.44
1.25
1.6
1.3
%
21.9
27.1
—
9
32
(3022493) Free Hemoglobin [Mass/volume] in Plasma
46
337
1.37
1.24
3.8
5.5
mg/l
55.9
77.4
1.16
33
234
(3011325) HIV 1+2 Ab [Presence] in Serum
6
25
2.40
1.24
1.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
8
36
2.22
1.24
1.3
1.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
9
45
2.00
1.23
2.7
1.5
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
8
37
2.16
1.21
1.0
1.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
27
395
0.68
1.19
5.3
4.8
u/ml
42.6
653.1
—
5
66
(3009871) Measles virus Ab [Titer] in Serum
11
200
0.55
1.18
1.5
1.6
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
6
26
2.31
1.18
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
28
189
1.48
1.18
1.0
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
63
489
1.29
1.17
2.8
2.2
umol/l
196.8
17.2
—
5
46
(21494434) Karyotype in Bone marrow
72
569
1.27
1.16
1.1
1.1
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
35
0.00
1.15
0.0
1.1
—
17.8
—
0
11
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
35
0.00
1.15
0.0
1.1
—
28.7
—
0
12
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
184
0.54
1.13
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
24
355
0.68
1.13
1.4
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
28
192
1.46
1.11
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
167
1444
1.16
1.10
1.4
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
50
380
1.32
1.10
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
79
974
0.81
1.10
1.2
1.2
u/ml
2.0
3.8
1.33
16
325
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
29
201
1.44
1.09
1.2
1.3
umol/l
2.9
3.2
0.17
24
188
(3006653) Thiamine [Moles/volume] in Blood
27
387
0.70
1.08
1.1
1.2
nmol/l
135.2
137.6
0.07
27
387
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
56
717
0.78
1.08
1.1
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
17
105
1.62
1.05
2.6
2.7
u/field
0.7
0.5
0.37
17
105
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
17
105
1.62
1.05
1.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
18
278
0.65
1.05
11.4
11.9
mmol/l
0.7
0.7
0.12
18
254
(3045424) Erythrocytes [Presence] in Urine
112
1325
0.84
1.03
1.8
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
308
2786
1.11
1.02
3.2
1.5
g/l
1.0
0.5
1.19
263
2361
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
95
789
1.21
1.01
1.3
1.3
—
43.2
—
0
5
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
40
530
0.75
1.01
1.1
1.0
mg/l
314.1
288.1
1.47
31
476
(3028707) Methadone [Presence] in Urine by Screen method
35
473
0.74
1.01
2.1
1.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
20
131
1.53
0.99
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
95
792
1.20
0.98
3.7
3.7
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
43
326
1.32
0.98
1.6
2.3
umol/l
55.5
58.2
0.19
35
261
(3046861) Legionella sp Ag [Presence] in Urine
7
36
1.95
0.97
1.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
75
914
0.82
0.96
1.1
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
11
186
0.59
0.95
1.5
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
43
328
1.31
0.95
1.0
1.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
79
956
0.82
0.95
1.2
1.2
u/ml
2.7
4.4
2.43
28
431
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
9
52
1.73
0.92
1.0
1.9
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
14
220
0.64
0.91
2.6
5.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
35
460
0.76
0.87
1.3
1.2
—
—
—
0
0
(44806420)
21
299
0.70
0.86
2.1
2.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
35
455
0.77
0.81
1.3
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
10
165
0.61
0.81
1.3
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
81
1.61
0.81
1.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
23
164
1.40
0.79
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
188
0.64
0.79
1.0
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
58
474
1.22
0.78
2.4
2.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
97
0.52
0.78
1.4
1.8
umol/l
16.1
18.4
—
5
97
(3023410) Appearance of Cerebral spinal fluid
78
657
1.19
0.77
1.4
1.5
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
18
123
1.46
0.77
1.1
1.2
ng/l
84.2
131.9
—
9
87
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
22
303
0.73
0.76
1.2
1.2
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
9
53
1.70
0.75
3.8
2.9
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
253
2312
1.10
0.75
2.9
1.5
g/l
0.0
0.0
0.00
224
2085
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
359
3332
1.08
0.74
3.2
1.4
g/l
3.9
3.9
0.01
252
2364
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
336
3112
1.08
0.73
3.3
1.5
g/l
3.6
3.0
10.65
256
2410
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
16
108
1.48
0.73
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
56
460
1.22
0.73
1.3
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
359
3336
1.08
0.72
3.2
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
86
1001
0.86
0.72
1.1
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
13
84
1.55
0.71
1.0
1.1
mg/g
9.2
8.4
0.20
13
79
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
359
3339
1.08
0.71
3.2
1.4
g/l
8.2
7.4
7.67
258
2456
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
248
2271
1.09
0.71
2.9
1.5
g/l
0.0
0.0
0.00
223
2077
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
16
109
1.47
0.70
1.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
37
465
0.79
0.69
1.5
1.6
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
37
465
0.79
0.69
1.0
1.1
nmol/l
0.2
6.5
—
5
99
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
120
1358
0.88
0.69
4.0
1.2
u/l
47.4
26.6
1.50
108
1165
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
59
1.53
0.68
1.3
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
92
798
1.15
0.67
1.7
2.3
ml
674.1
664.1
0.09
52
546
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
336
3129
1.08
0.66
3.2
1.5
g/l
9.7
10.3
1.81
275
2605
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
12
78
1.54
0.65
1.0
1.0
—
—
—
0
0
(4015189)
21
281
0.75
0.63
1.5
2.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
78
903
0.86
0.63
1.0
1.1
au/ml
10.1
14.3
—
6
38
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
152
1683
0.90
0.62
1.2
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
150
1662
0.90
0.62
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
29
369
0.79
0.61
1.1
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
60
507
1.18
0.61
2.4
2.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
13
187
0.69
0.60
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
2656
27092
0.97
0.60
7.1
3.9
%
22.2
24.3
8.46
1702
13545
(40768446) Kidney Pathology biopsy report
21
278
0.75
0.60
1.3
1.6
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
4.0
—
0
16
(3035082) Kappa light chains [Mass/volume] in Urine
0
22
0.00
0.59
0.0
1.0
—
0.0
—
0
9
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.0
—
12745.6
—
0
9
(3022621) pH of Urine by Test strip
516
5433
0.95
0.59
3.4
3.0
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
1.1
—
0
18
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
158
1738
0.91
0.58
1.2
1.4
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
7
114
0.61
0.57
1.3
1.4
mu/l
365.4
646.8
—
7
106
(3017509) Phencyclidine [Presence] in Urine
6
35
1.71
0.57
1.2
1.3
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
7
115
0.61
0.57
1.3
1.5
%
77.9
71.5
—
7
107
(3051101) Glucose [Moles/volume] in Cord blood
15
207
0.72
0.56
4.1
6.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
105
1177
0.89
0.55
1.0
1.1
iu/ml
60.6
10720.2
0.56
31
226
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
15
107
1.40
0.55
1.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
16
116
1.38
0.54
2.4
1.7
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
26
328
0.79
0.53
1.2
1.2
g/l
38.1
39.5
0.21
15
163
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
11
74
1.49
0.53
1.0
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
49
578
0.85
0.53
1.2
1.2
mmol/l
12.1
11.9
0.05
20
166
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
47
556
0.84
0.53
1.5
1.7
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
97
0.62
0.52
2.3
2.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
97
0.62
0.52
1.3
1.6
umol/l
39.7
46.1
—
6
97
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
100
0.60
0.51
2.3
2.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
16
214
0.75
0.51
1.1
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1920
18781
1.03
0.51
4.1
3.7
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
92
1.41
0.50
1.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
41
1.46
0.50
1.0
2.6
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
36
298
1.21
0.48
1.1
1.1
ng/l
76.0
394.7
—
8
75
(3017704) Immunofixation for Urine
54
465
1.16
0.48
1.8
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
21
266
0.79
0.46
1.3
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
21
164
1.28
0.46
1.4
1.2
mu/l
89.7
65.0
0.23
15
116
(3020191) Ethanol [Moles/volume] in Serum or Plasma
52
601
0.86
0.46
1.3
1.4
promille
0.9
1.3
1.03
37
453
(4211845)
51
439
1.16
0.46
4.0
3.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
2010
20496
0.98
0.46
1.6
1.5
nmol/l
18.5
20.3
5.91
1822
17309
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
53
458
1.16
0.45
1.2
1.1
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
5
83
0.60
0.45
1.0
1.3
pmol/l
4.6
13.4
—
5
72
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
23
183
1.26
0.44
1.0
1.1
%
87.1
86.4
—
10
90
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
13
175
0.74
0.44
1.0
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
51
1.37
0.44
1.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
180
1934
0.93
0.43
2.6
3.0
nmol/l
0.8
0.8
0.11
131
1498
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
14
104
1.35
0.43
1.0
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
5
31
1.61
0.43
1.2
1.1
mmol/l
8.8
8.2
—
5
31
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
303
3196
0.95
0.42
1.5
1.9
u/l
37.3
38.6
0.54
271
2752
(3011335) Digoxin [Mass/volume] in Serum or Plasma
13
96
1.35
0.41
2.2
2.4
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.3
—
2.2
—
0
16
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
8
59
1.36
0.41
1.3
1.1
u/l
17.0
13.4
—
8
59
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
3.4
—
0
17
(3051593) INR in Capillary blood by Coagulation assay
41
476
0.86
0.40
6.0
10.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
60
530
1.13
0.40
1.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
101
0.69
0.39
1.1
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
13
97
1.34
0.39
1.5
1.5
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
4.3
—
—
—
0
0
(3006969) Lambda light chains [Mass/volume] in Urine
0
19
0.00
0.39
0.0
1.0
—
0.0
—
0
12
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
14
106
1.32
0.39
1.2
2.6
—
36.1
—
0
20
(3008116) Ketones [Moles/volume] in Urine by Test strip
19
151
1.26
0.38
1.2
1.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
80
1.38
0.38
1.0
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
34
289
1.18
0.37
1.6
2.0
ug/l
70.6
52.0
1.01
34
281
(3028717) Thiamine [Mass/volume] in Blood
9
70
1.29
0.36
1.2
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
46
403
1.14
0.36
4.3
3.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
12
90
1.33
0.35
12.0
9.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
10
73
1.37
0.34
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
41
359
1.14
0.33
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
228
2400
0.95
0.32
2.2
2.3
ug/min
123.9
118.1
0.06
121
1407
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
24
201
1.19
0.32
1.6
2.3
ug/l
1.0
0.9
0.21
24
187
(3000330) Specific gravity of Urine by Test strip
431
4467
0.96
0.32
5.0
3.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
23
192
1.20
0.32
2.2
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
52
1.35
0.31
1.3
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
273
2611
1.05
0.30
2.8
1.5
g/l
35.6
37.6
5.68
235
2203
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
54
1.30
0.30
1.3
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
109
0.73
0.29
2.9
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
60
660
0.91
0.28
1.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
42
373
1.13
0.28
1.3
1.5
umol/l
18.1
8.9
0.81
32
261
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
16
130
1.23
0.28
1.1
1.2
%
80.8
78.4
—
5
49
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
31
355
0.87
0.28
1.0
1.1
ratio
1.1
1.1
—
10
122
(3003740) Influenza virus B Ag [Presence] in Specimen
60
659
0.91
0.28
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1860
18857
0.98
0.27
4.0
2.8
ug/l
1.6
0.7
20.13
1442
13247
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
21
177
1.19
0.27
1.0
1.1
%
68.6
87.6
—
8
91
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
40
357
1.12
0.26
1.1
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
86
1.28
0.26
1.2
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
55
603
0.91
0.25
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
137
1296
1.06
0.25
1.2
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
193
1846
1.05
0.24
1.4
1.3
mg/l
690.6
551.7
1.62
187
1746
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
19
161
1.18
0.24
1.1
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
36
322
1.12
0.23
1.4
2.0
umol/l
83.1
125.6
0.79
18
174
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
169
1613
1.05
0.23
1.3
1.2
mmol/l
3.7
3.9
1.79
157
1516
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
20
171
1.17
0.23
1.0
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
21
181
1.16
0.22
2.2
2.6
mmol/l
6.7
8.1
0.97
14
116
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
46
419
1.10
0.22
2.1
2.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
189
1812
1.04
0.22
3.7
3.5
mg/l
35.7
26.7
2.08
124
1174
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
86
806
1.07
0.22
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
30
336
0.89
0.21
1.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.0
—
139.4
—
0
10
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(4198724)
13
156
0.83
0.21
1.6
1.5
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
82
874
0.94
0.21
1.2
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
163
1702
0.96
0.21
1.7
1.5
nmol/l
0.9
0.8
0.70
141
1394
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
5.8
—
0.3
—
0
13
(3034614) HLA Ag [Interpretation]
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
34
306
1.11
0.20
1.4
1.3
umol/l
59.7
21.8
5.26
34
287
(3036071) Salmonella sp Ab [Titer] in Serum
17
198
0.86
0.20
1.1
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
10
80
1.25
0.20
1.2
1.1
—
—
—
0
0
(3024316) Viscosity of Plasma
0
14
0.00
0.20
0.0
1.4
—
1.4
—
0
7
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
123
1171
1.05
0.20
1.1
1.2
miu/ml
168.8
218.0
0.89
37
474
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
35
386
0.91
0.20
1.1
1.3
—
—
—
0
0
(4133840)
20
174
1.15
0.19
1.3
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
68
726
0.94
0.19
1.2
1.4
g/l
7.7
6.9
0.60
37
510
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
6
52
1.15
0.19
1.5
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
53
1.13
0.18
1.0
2.0
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
68
725
0.94
0.18
1.2
1.4
g/l
0.4
0.4
0.22
37
513
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
18
206
0.87
0.18
1.4
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
22
248
0.89
0.18
1.5
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(4212803)
7
59
1.19
0.18
1.0
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
168
1618
1.04
0.17
1.4
1.4
e6/l
30.7
22.1
0.19
128
1274
(40768443) Skin Pathology biopsy report
311
3193
0.97
0.17
1.2
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
5
68
0.74
0.17
1.4
1.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
168
1621
1.04
0.16
1.5
1.4
e6/l
740.0
1615.0
1.10
137
1351
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
16
183
0.87
0.16
1.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
21
187
1.12
0.15
1.0
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
9
78
1.15
0.15
1.1
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
51
479
1.06
0.14
1.5
1.3
nmol/l
1.1
1.2
0.21
43
363
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
12
139
0.86
0.14
1.3
1.4
mmol/l
7.3
9.3
—
5
75
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
135
1398
0.97
0.14
1.2
1.5
—
—
—
0
0
(4062490)
69
726
0.95
0.14
1.2
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
69
725
0.95
0.13
1.2
1.4
g/l
2.7
3.0
1.03
38
508
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
69
724
0.95
0.13
1.1
1.1
—
22.7
—
0
9
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
33
306
1.08
0.12
1.2
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
45
423
1.06
0.12
1.1
1.1
mg/l
360.9
288.7
0.94
38
384
(4027681)
34
316
1.08
0.12
1.3
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1895
18816
1.01
0.12
1.8
1.7
pmol/l
10864329.8
34471909.2
2.04
1528
15288
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
18
162
1.11
0.11
1.1
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
35
374
0.94
0.11
1.1
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
16
143
1.12
0.11
1.0
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
110
1137
0.97
0.11
1.2
1.6
g/l
0.8
0.9
0.25
75
859
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
17
153
1.11
0.11
1.2
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
24
260
0.92
0.11
1.2
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
33
352
0.94
0.10
1.8
2.1
u/ml
1058.5
810.8
0.85
33
346
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
38
358
1.06
0.10
1.5
1.2
%
68.9
51.3
—
7
32
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
44
1.14
0.10
3.6
1.4
umol/24h
757.8
318.8
—
5
44
(3028679) Herpes simplex virus Ab [Presence] in Serum
30
281
1.07
0.09
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1104
11121
0.99
0.09
15.3
7.1
—
—
—
0
0
(3024471) HLA-A [Type]
21
194
1.08
0.09
1.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
25
233
1.07
0.09
1.1
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
12
134
0.90
0.08
1.1
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
15
136
1.10
0.08
1.1
1.4
%
57.0
46.9
—
8
55
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
48
459
1.05
0.08
2.1
2.1
ug/min
25.1
166.7
—
8
121
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
32
302
1.06
0.08
1.1
1.1
iu/ml
144.5
202.3
1.04
32
297
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
112
1091
1.03
0.08
1.9
2.2
mg/l
42.7
25.9
1.39
30
288
(3025315) Body weight
7
68
1.03
0.07
5.0
4.9
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
30
317
0.95
0.07
1.1
1.1
u/l
1.0
1.1
0.26
17
144
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
39
408
0.96
0.07
1.0
1.1
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
7
84
0.83
0.07
1.0
1.8
mmol/l
8.9
7.4
—
7
40
(3038177) Helicobacter pylori Ab [Presence] in Serum
107
1093
0.98
0.06
1.3
1.3
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
10
111
0.90
0.06
1.1
1.2
—
92.6
—
0
6
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
20
212
0.94
0.05
1.1
1.7
%
243.7
187.6
0.95
20
198
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
201
1987
1.01
0.04
1.5
1.9
mg/l
9.8
11.3
1.96
185
1839
(3034426) Prothrombin time (PT)
22
231
0.95
0.04
1.1
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
16
170
0.94
0.04
1.4
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
21
220
0.95
0.03
1.1
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
44
429
1.03
0.03
1.8
2.1
mmol/l
9.3
9.1
0.10
38
323
(3020491) Glucose [Moles/volume] in Blood
59
580
1.02
0.02
1.6
2.0
mmol/l
7.5
6.9
0.84
49
385
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
46
452
1.02
0.01
1.1
1.1
mg/l
52.5
40.7
0.91
39
393
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
77
776
0.99
0.00
1.3
1.3
nmol/l
1.4
1.4
0.01
71
700
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
12
124
0.97
0.00
1.4
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
19
191
0.99
0.00
1.3
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
187
1.02
0.00
1.0
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
16
165
0.97
0.00
1.1
1.1
umol/24h
0.6
0.7
—
7
70
(3000034) Microalbumin [Mass/volume] in Urine
87
870
1.00
0.00
2.6
3.1
mg/l
27.7
38.7
0.64
67
630
(3013293) Extractable nuclear Ab [Presence] in Serum
11
112
0.98
0.00
1.1
1.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
11
112
0.98
0.00
10.5
12.2
mmol/l
5.1
5.1
0.02
11
112
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
19
185
1.03
0.00
1.3
1.2
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
9.0
—
—
—
0
0
(3014171) Thiocyanate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
152.3
—
0
6
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
6
65
0.92
0.00
1.3
1.5
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
170.3
—
0
6
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
61
0.98
0.00
1.3
1.0
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
7
71
0.99
0.00
1.1
1.2
umol/24h
1.5
1.8
—
7
71
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033463) Neutrophils [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5
58
0.86
0.00
1.0
1.1
—
13.6
—
0
11
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
88
0.91
0.00
1.7
1.6
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_SECONDARY_NAS_EXALLC – Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).